| scholarly article | Q13442814 |
| P2093 | author name string | Qian Liu | |
| Ming Yan | |||
| Guo-Bing Shi | |||
| Yu-Feng Chen | |||
| Qing-Chun Zhao | |||
| Da-Sheng Dang | |||
| P433 | issue | 11 | |
| P921 | main subject | clopidogrel | Q410237 |
| omeprazole | Q422210 | ||
| P304 | page(s) | 1293-1297 | |
| P577 | publication date | 2012-10-09 | |
| P1433 | published in | Genetic Testing and Molecular Biomarkers | Q15753742 |
| P1476 | title | The influence of omeprazole on platelet inhibition of clopidogrel in various CYP2C19 mutant alleles | |
| P478 | volume | 16 |
| Q24185813 | Antiplatelet and anticoagulant agents for preventing recurrence of peripheral vascular thrombosis in patients with Antiphospholipid syndrome |
| Q41874943 | Cigarette smoking might weaken the prognostic significance of cytochrome P450 2C19*2 polymorphism in acute myocardial infarction patients |
| Q34873839 | Clinical outcomes associated with proton pump inhibitor use among clopidogrel-treated patients within CYP2C19 genotype groups following acute myocardial infarction |
| Q36365500 | Pharmacogenetics of drug-drug interaction and drug-drug-gene interaction: a systematic review on CYP2C9, CYP2C19 and CYP2D6. |
| Q38233284 | Platelet function inhibitors and platelet function testing in neurointerventional procedures. |
| Q51507688 | Proton Pump Inhibitors in Cardiovascular Disease: Drug Interactions with Antiplatelet Drugs. |
Search more.